Survey of Ophthalmology
Volume 50, Issue 4 , Pages 351-363 , July 2005

Scleritis

  • Narciss Okhravi, PhD, FRCOphth

      Affiliations

    • Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, City Road, London EC1V 2PD, United Kingdom
    • ,
  • Bola Odufuwa, FRCOphth

      Affiliations

    • Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, City Road, London EC1V 2PD, United Kingdom
    • ,
  • Peter McCluskey, MD, FRCS

      Affiliations

    • Department of Ophthalmology, Royal Prince Alfred Hospital, Missenden Road, Camperdown, New South Wales, 2050, Australia
    • ,
  • Susan Lightman, PhD, FRCOphth

      Affiliations

    • Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, City Road, London EC1V 2PD, United Kingdom
    • Corresponding Author InformationReprint address: Professor Susan Lightman, Department of Clinical Ophthalmology, Moorfields Eye Hospital, City Road, London EC1V 2PD, UK.

References 

  1. Afshari NA, Afshari MA, Foster CS. Inflammatory conditions of the eye associated with rheumatic diseases. Curr Rheumatol Rep. 2001;3:453–458
  2. Akova YA, Jabbur NS, Foster CS. Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy. Ophthalmology. 1993;100:1775–1781
  3. Bambery P, Gupta A, Sakhuja V, et al. Ocular manifestations of Wegener's granulomatosis in north India. Sarcoidosis. 1988;5:132–135
  4. Benson WE. Posterior scleritis. Surv Ophthalmol. 1988;32:297–316
  5. Bernauer W. Infectious scleritis and surgically induced scleritis. In:  McCluskey P editors. Scleritis. London: BMJ Books; 2001;
  6. Bernauer W. [Vision disorders in inflammatory-rheumatic diseases]. Ther Umsch. 1996;53:58–67
  7. Bernauer W, Allan BD, Dart JK. Successful management of Aspergillus scleritis by medical and surgical treatment. Eye. 1998;12(Pt 2):311–316
  8. Bernauer W, Büchi E.R, Daicker B: Immunopathological findings in posterior scleritis. Int Ophthalmol 18:229–31, 1994
  9. Bernauer W, Watson PG, Daicker B, et al. Cells perpetuating the inflammatory response in scleritis. Br J Ophthalmol. 1994;78:381–385
  10. Bhagat S, Ramaesh K, Wharton SB, et al. Spontaneous acute scleritis and scleral necrosis in choroidal malignant melanoma. Eye. 1999;13(Pt 6):793–795
  11. Bialasiewicz AA. [Eye manifestations of Lyme borreliosis]. Ophthalmologe. 1992;89:W47–W59
  12. Bouza E, Merino P, Muñoz P, et al. Ocular tuberculosis. A prospective study in a general hospital. Medicine (Baltimore). 1997;76:53–61
  13. Brod RD, Saul RF. Nodular posterior scleritis. Arch Ophthalmol. 1990;108:1170–1171
  14. Brooks JG, Mills RA, Coster DJ. Nocardial scleritis. Am J Ophthalmol. 1992;114:371–372
  15. Brunette I, Stulting RD. Sporothrix schenckii scleritis. Am J Ophthalmol. 1992;114:370–371
  16. Cakiner T, Karaçorlu MA. Ophthalmic findings of newly diagnosed leprosy patients in Istanbul Leprosy Hospital, Turkey. Acta Ophthalmol Scand. 1998;76:100–102
  17. Calthorpe CM, Watson PG, McCartney AC. Posterior scleritis: a clinical and histological survey. Eye. 1988;2:267–277
  18. Caronia R, Liebmann J, Speaker M, et al. Corynebacterium scleritis. Am J Ophthalmol. 1994;117:405–406
  19. Casey R, Flowers CW, Jones DD, et al. Anterior nodular scleritis secondary to syphilis. Arch Ophthalmol. 1996;114:1015–1016
  20. Charles SJ, Meyer PA, Watson PG. Diagnosis and management of systemic Wegener's granulomatosis presenting with anterior ocular inflammatory disease. Br J Ophthalmol. 1991;75:201–207
  21. Choudhry S, Rao SK, Biswas J, et al. Necrotizing nocardial scleritis with intraocular extension: a case report. Cornea. 2000;19:246–248
  22. Dana MR, Hochman MA, Viana MA, et al. Ocular manifestations of leprosy in a noninstitutionalized community in the United States. Arch Ophthalmol. 1994;112:626–629
  23. Di Girolamo N, Lloyd A, McCluskey P, et al. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol. 1997;150:653–666
  24. Di Girolamo N, Visvanathan K, Lloyd A, et al. Expression of TNF-alpha by human plasma cells in chronic inflammation. J Leukoc Biol. 1997;61:667–678
  25. Dorey SE, Clark BJ, Christopoulos VA, et al. Orbital lymphoma misdiagnosed as scleritis. Ophthalmology. 2002;109:2347–2350
  26. Dougherty PJ, Binder PS, Mondino BJ, et al. Acanthamoeba sclerokeratitis. Am J Ophthalmol. 1994;117:475–479
  27. Enzenauer RW, Enzenauer RJ, Reddy VB, et al. Treatment of scleromalacia perforans with dura mater grafting. Ophthalmic Surg. 1992;23:829–832
  28. Finger PT, Perry HD, Packer S, et al. Posterior scleritis as an intraocular tumour. Br J Ophthalmol. 1990;74:121–122
  29. Fong LP, Sainz de la Maza M, Rice BA, et al. Immunopathology of scleritis. Ophthalmology. 1991;98:472–479
  30. Foster CS, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology. 1984;91:1253–1263
  31. Fraunfelder FW, Fraunfelder FT, Jensvold B. Scleritis and other ocular side effects associated with pamidronate disodium. Am J Ophthalmol. 2003;135:219–222
  32. Furukawa H, Hamada T, Nagaya K, et al. [A case of necrotizing scleritis associated with Epstein-Barr virus infection]. Nippon Ganka Gakkai Zasshi. 1993;97:1337–1342
  33. Garner A. Pathogenesis of acanthamoebic keratitis: hypothesis based on a histological analysis of 30 cases. Br J Ophthalmol. 1993;77:366–370
  34. Godkin AJ, Dinning WJ, Anderson MG. Scleritis associated with coxsackle B type 5 infection. Eye. 1994;8:357–358
  35. Hakin KN, Ham J, Lightman SL. Use of cyclosporin in the management of steroid dependent non-necrotising scleritis. Br J Ophthalmol. 1991;75:340–341
  36. Hakin KN, Watson PG. Systemic associations of scleritis. Int Ophthalmol Clin. 1991;31:111–129
  37. Hall AJ, Barton K, Watson PG, et al. Scleritis in association with poststreptococcal vasculitis. Arch Ophthalmol. 1993;111:1324–1325
  38. Harper SL, Letko E, Samson CM, et al. Wegener's granulomatosis: the relationship between ocular and systemic disease. J Rheumatol. 2001;28:1025–1032
  39. Heiligenhaus A, Michel D, Koch JM. Nodular scleritis in a patient with sarcoidosis. Br J Ophthalmol. 2003;87:507–508
  40. Helm CJ, Holland GN, Webster RG, et al. Combination intravenous ceftazidime and aminoglycosides in the treatment of pseudomonal scleritis. Ophthalmology. 1997;104:838–843
  41. Huang FC, Huang SP, Tseng SH. Management of infectious scleritis after pterygium excision. Cornea. 2000;19:34–v9
  42. Hunyor AP, Harper CA, O'Day J, et al. Ocular-central nervous system lymphoma mimicking posterior scleritis with exudative retinal detachment. Ophthalmology. 2000;107:1955–1959
  43. Hwang YS, Chen YF, Lai CC, et al. Infectious scleritis after use of immunomodulators. Arch Ophthalmol. 2002;120:1093–1094
  44. Illingworth CD, Cook SD. Acanthamoeba keratitis. Surv Ophthalmol. 1998;42:493–508
  45. Jabs DA, Mudun A, Dunn JP, et al. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000;130:469–476
  46. Jager MJ, Chodosh J, Huang AJ, et al. Aspergillus niger as an unusual cause of scleritis and endophthalmitis. Br J Ophthalmol. 1994;78:584–586
  47. Jain R, Ionides A, Pavesio C, et al. Scleritis as a presenting feature of Takayasu's disease. Br J Ophthalmol. 2000;84:801
  48. Jayson MI, Jones DE. Scleritis and rheumatoid arthritis. Ann Rheum Dis. 1971;30:343–347
  49. Joysey VC, Roger JH, Ashworth F, et al. Parallel studies of HLA antigens in patients with rheumatic heart disease and scleritis: comparisons with three control populations. J Rheumatol. 1977;3(Suppl):84–88
  50. Kachmaryk M, Bouchard CS, Duffner LA. Bilateral fascia lata patch grafts in a patient with progressive scleromalacia perforans. Ophthalmic Surg Lasers. 1996;27:397–400
  51. Kachmaryk M, Bouchard CS, Duffner LA. Bilateral fascia lata patch grafts in a patient with progressive scleromalacia perforans. Ophthalmic Surg Lasers. 1996;27:397–400
  52. Kalina PH, Garrity JA, Herman DC, et al. Role of testing for anticytoplasmic autoantibodies in the differential diagnosis of scleritis and orbital pseudotumor. Mayo Clin Proc. 1990;65:1110–1117
  53. Karia N, Doran J, Watson SL, et al. Surgically induced necrotizing scleritis in a patient with ankylosing spondylitis. J Cataract Refract Surg. 1999;25:597–600
  54. Kim RY, Anderlini P, Naderi AA, et al. Scleritis as the initial clinical manifestation of graft-versus-host disease after allogenic bone marrow transplantation. Am J Ophthalmol. 2002;133:843–845
  55. Kim RY, Seiff SR, Howes EL, et al. Necrotizing scleritis secondary to conjunctival squamous cell carcinoma in acquired immunodeficiency syndrome. Am J Ophthalmol. 1990;109:231–233
  56. Knox CM, Whitcher JP, Cevellos V, et al. Nocardia scleritis. Am J Ophthalmol. 1997;123:713–714
  57. Kouda N, Sasaki H, Harada S, et al. Early manifestation of Vogt-Koyanagi-Harada disease as unilateral posterior scleritis. Jpn J Ophthalmol. 2002;46:590–593
  58. Krist D, Wenkel H. Posterior scleritis associated with Borrelia burgdorferi (Lyme disease) infection. Ophthalmology. 2002;109:143–145
  59. Kumar B, Crawford GJ, Morlet GC. Scedosporium prolificans corneoscleritis: a successful outcome. Aust NZ J Ophthalmol. 1997;25:169–171
  60. Lachmann SM, Hazleman BL, Watson PG. Scleritis and associated disease. Br Med J. 1978;1:88–90
  61. Langford CA. Wegener's granulomatosis: current and upcoming therapies. Arthritis Res Ther. 2003;5:180–191
  62. Langford CA, Talar-Williams C, Sneller MC. Mycophenolate mofetil for remission maintenance in the treatment of Wegeners granulomatosis. Arthritis Rheum. 2004;51:278–283
  63. Larkin G, Lightman S. Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease. Ophthalmology. 1999;106:370–374
  64. Leahey AB, Gottsch JD, Stark WJ. Clinical experience with N-butyl cyanoacrylate (Nexacryl) tissue adhesive. Ophthalmology. 1993;100:173–180
  65. Lee GA, Gray TB, Dart JK, et al. Acanthamoeba sclerokeratitis: treatment with systemic immunosuppression. Ophthalmology. 2002;109:1178–1182
  66. Lindenmuth KA, Sugar A, Kincaid MC, et al. Invasive squamous cell carcinoma of the conjunctiva presenting as necrotizing scleritis with scleral perforation and uveal prolapse. Surv Ophthalmol. 1988;33:50–54
  67. Livir-Rallatos C, El-Shabrawi Y, Zatirakis P, et al. Recurrent nodular scleritis associated with varicella zoster virus. Am J Ophthalmol. 1998;126:594–597
  68. Lyne AJ, Pitkeathley DA. Episcleritis and scleritis. Association with connective tissue disease. Arch Ophthalmol. 1968;80:171–176
  69. MacKenzie FD, Hirst LW, Kynaston B, et al. Recurrence rate and complications after beta irradiation for pterygia. Ophthalmology. 1991;98:1776–1780discussion 1781
  70. Mader TH, Stulting RD, Crosswell HH. Bilateral paralimbal scleromalacia perforans. Am J Ophthalmol. 1990;109:233–234
  71. Mahmood MA, Al-Rajhi A, Riley F, et al. Sclerokeratitis: an unusual presentation of squamous cell carcinoma of the conjunctiva. Ophthalmology. 2001;108:553–558
  72. Makins R, Ballinger A. Gastrointestinal side effects of drugs. Expert Opin Drug Saf. 2003;2:421–429
  73. Margo CE, Pavan PR. Mycobacterium chelonae conjunctivitis and scleritis following vitrectomy. Arch Ophthalmol. 2000;118:1125–1128
  74. Marsh RJ, Cooper M. Ophthalmic herpes zoster. Eye. 1993;7:350–370
  75. McCluskey P, Wakefield D. Current concepts in the management of scleritis. Aust NZ J Ophthalmol. 1988;16:169–176
  76. McCluskey P, Wakefield D. Intravenous pulse methylprednisolone in scleritis. Arch Ophthalmol. 1987;105:793–797
  77. McCluskey PJ, Watson PG, Lightman S, et al. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology. 1999;106:2380–2386
  78. McGavin DD, Williamson J, Forrester JV, et al. Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol. 1976;60:192–226
  79. Messmer EM, Foster CS. Destructive corneal and scleral disease associated with rheumatoid arthritis. Medical and surgical management. Cornea. 1995;14:408–417
  80. Moriarty AP, Crawford GJ, McAllister IL, et al. Fungal corneoscleritis complicating beta-irradiation-induced scleral necrosis following pterygium excision. Eye. 1993;7(Pt 4):525–528
  81. Moriarty AP, Crawford GJ, McAllister IL, et al. Bilateral streptococcal corneoscleritis complicating beta irradiation induced scleral necrosis. Br J Ophthalmol. 1993;77:251–252
  82. Moriarty AP, Crawford GJ, McAllister IL, et al. Severe corneoscleral infection. A complication of beta irradiation scleral necrosis following pterygium excision. Arch Ophthalmol. 1993;111:947–951
  83. Moshari A, Cheeseman EW, McLean IW. Totally necrotic choroidal and ciliary body melanomas: associations with prognosis, episcleritis, and scleritis. Am J Ophthalmol. 2001;131:232–236
  84. Nanda M, Pflugfelder SC, Holland S. Fulminant pseudomonal keratitis and scleritis in human immunodeficiency virus-infected patients. Arch Ophthalmol. 1991;109:503–505
  85. Nanda M, Pflugfelder SC, Holland S. Mycobacterium tuberculosis scleritis. Am J Ophthalmol. 1989;108:736–737
  86. Naseri A, Good WV, Cunningham ET. Herpes zoster virus sclerokeratitis and anterior uveitis in a child following varicella vaccination. Am J Ophthalmol. 2003;135:415–417
  87. Nguyen QD, Foster CS. Scleral patch graft in the management of necrotizing scleritis. Int Ophthalmol Clin. 1999;39:109–131
  88. O'Donoghue E, Lightman S, Tuft S, et al. Surgically induced necrotising sclerokeratitis (SINS)—precipitating factors and response to treatment. Br J Ophthalmol. 1992;76:17–21
  89. Ormerod LD, Puklin JE, McHenry JG, et al. Scleral flap necrosis and infectious endophthalmitis after cataract surgery with a scleral tunnel incision. Ophthalmology. 1993;100:159–163
  90. Perlstein SH, Yablonski ME. Spontaneous remission of glaucoma in scleromalacia perforans: a case report. Ann Ophthalmol. 1984;16:229–230
  91. Pitkeathly DA, Howitt G, Lyne AJ. Scleritis and aortic incompetence. Two manifestations of connective tissue disease. Ann Rheum Dis. 1970;29:477–482
  92. Polaczek-Kornecka A, Mirkiewicz-Sieradzka B, Heitzman J, et al. [Scleritis resembling choroidal melanoma: a case report]. Klin Oczna. 1999;101:135–137
  93. Poon A, MacLean H, McKelvie P. Recurrent scleritis in lepromatous leprosy. Aust NZ J Ophthalmol. 1998;26:51–55
  94. Pope J, Sternberg P, McLane NJ, et al. Mycobacterium chelonae scleral abscess after removal of a scleral buckle. Am J Ophthalmol. 1989;107:557–558
  95. Preoteasa D. [Tuberculous sclerokeratitis and cutaneous tuberculids]. Oftalmologia. 1993;37:215–220
  96. Quinlan MP, Hitchings RA. Angle-closure glaucoma secondary to posterior scleritis. Br J Ophthalmol. 1978;62:330–335
  97. Radford R, Brahma A, Armstrong M, et al. Severe sclerokeratitis due to Pseudomonas aeruginosa in noncontact-lens wearers. Eye. 2000;14(Pt 1):3–7
  98. Reynolds MG, Alfonso E. Treatment of infectious scleritis and keratoscleritis. Am J Ophthalmol. 1991;112:543–547
  99. Riono WP, Hidayat AA, Rao NA. Scleritis: a clinicopathologic study of 55 cases. Ophthalmology. 1999;106:1328–1333
  100. Rodriguez-Ares MT, De Rojas Silva MV, Pereiro M, et al. Aspergillus fumigatus scleritis. Acta Ophthalmol Scand. 1995;73:467–469
  101. Sainz de la Maza M, Foster CS. Necrotizing scleritis after ocular surgery. A clinicopathologic study. Ophthalmology. 1991;98:1720–1726
  102. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis-associated uveitis. Ophthalmology. 1997;104:58–63
  103. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with systemic vasculitic diseases. Ophthalmology. 1995;102:687–692
  104. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with rheumatoid arthritis and with other systemic immune-mediated diseases. Ophthalmology. 1994;101:1281–1286discussion 1287–8
  105. Sainz de la Maza M, Foster CS, Jabbur NS, et al. Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy. Arch Ophthalmol. 2002;120:15–19
  106. Sainz de la Maza M, Hemady RK, Foster CS. Infectious scleritis: report of four cases. Doc Ophthalmol. 1993;83:33–41
  107. Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology. 1994;101:389–396
  108. Schuman JS, Weinberg RS, Ferry AP, et al. Toxoplasmic scleritis. Ophthalmology. 1988;95:1399–1403
  109. Scott JA, Clearkin LG. Surgically induced diffuse scleritis following cataract surgery. Eye. 1994;8(Pt 3):292–297
  110. Sen HN, Suhler EB, Al-Khatib SQ, et al. Mycophenolate mofetil for the treatment of scleritis. Ophthalmology. 2003;110:1750–1755
  111. Shah P, Luqmani RA, Murray PI, et al. Posterior scleritis—an unusual manifestation of Cogan's syndrome. Br J Rheumatol. 1994;33:774–775
  112. Shah SS, Lowder CY, Schmitt MA, et al. Low-dose methotrexate therapy for ocular inflammatory disease. Ophthalmology. 1992;99:1419–1423
  113. Sharma A, Kaur R, Kumar S, et al. Fibrin glue versus N-butyl-2-cyanoacrylate in corneal perforations. Ophthalmology. 2003;110:291–298
  114. Smith JR, Cunningham ET. Atypical presentations of ocular toxoplasmosis. Curr Opin Ophthalmol. 2002;13:387–392
  115. Smith JR, Levinson RD, Holland GN, et al. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum. 2001;45:252–257
  116. Snell R, Lemp M. Clinical anatomy of the eye. Malden: Blackwell Scientific Publications; 1989;pp 125–6
  117. Sridhar MS, Cohen EJ, Rapuano CJ, et al. Nocardia asteroides sclerokeratitis in a contact lens wearer. CLAO J. 2002;28:66–68
  118. Sykes SO, Riemann C, Santos CI, et al. Haemophilus influenzae associated scleritis. Br J Ophthalmol. 1999;83:410–413
  119. Tanemoto K, Ishikawa H, Kigasawa K, et al. [Detection of mycobacterial DNA with polymerase chain reaction in eye discharge and gastric juices in a case of scleritis]. Nippon Ganka Gakkai Zasshi. 1997;101:97–101
  120. Thurairajan G, Hope-Ross MW, Situnayake RD, et al. Polyarthropathy, orbital myositis and posterior scleritis: an unusual adverse reaction to influenza vaccine. Br J Rheumatol. 1997;36:120–123
  121. Tuft SJ, Watson PG. Progression of scleral disease. Ophthalmology. 1991;98:467–471
  122. Vanathi M, Sharma N, Titiyal JS, et al. Tectonic grafts for corneal thinning and perforations. Cornea. 2002;21:792–797
  123. Veenashree MP, Sangwan VS, Vemuganti GK, et al. Acute scleritis as a manifestation of congenital erythropoietic porphyria. Cornea. 2002;21:530–531
  124. Wakefield D, McCluskey P. Cyclosporin therapy for severe scleritis. Br J Ophthalmol. 1989;73:743–746
  125. Walton RC, Reed KL. Herpes zoster ophthalmicus following bone marrow transplantation in children. Bone Marrow Transplant. 1999;23:1317–1320
  126. Watanabe K, Kato T, Hayasaka S. Concurrent bilateral posterior scleritis and Vogt-Koyanagi-Harada disease in a patient with positive rheumatoid factor. Ophthalmologica. 1997;211:316–319
  127. Watson PG, Bovey E. Anterior segment fluorescein angiography in the diagnosis of scleral inflammation. Ophthalmology. 1985;92:1–11
  128. Watson PG, Hazleman BL. The sclera in systemic disorders. London, Philadelphia: W.B. Saunders and Co. Ltd; 1976;
  129. Watson PG, Lobascher D. The diagnosis and management of episcleritis and scleritis. Trans Ophthalmol Soc UK. 1965;85:369–378
  130. Wilhelmus KR, Grierson I, Watson PG. Histopathologic and clinical associations of scleritis and glaucoma. Am J Ophthalmol. 1981;91:697–705
  131. Womack LW, Liesegang TJ. Complications of herpes zoster ophthalmicus. Arch Ophthalmol. 1983;101:42–45
  132. Yap EY, Robertson DM, Buettner H. Scleritis as an initial manifestation of choroidal malignant melanoma. Ophthalmology. 1992;99:1693–1697
  133. Yeo JH, Jakobiec FA, Iwamoto T, et al. Metastatic carcinoma masquerading as scleritis. Ophthalmology. 1983;90:184–194
  134. Younan N, McClellan K. Squamous cell carcinoma with necrotizing scleritis. Aust NZ J Ophthalmol. 1999;27:149–151
  135. Zamir E, Read RW, Smith RE, et al. A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis. Ophthalmology. 2002;109:798–805discussion 805–7

 The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

PII: S0039-6257(05)00039-1

doi: 10.1016/j.survophthal.2005.04.001

Survey of Ophthalmology
Volume 50, Issue 4 , Pages 351-363 , July 2005

Article Tools

* Image Usage & Resolution